Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Hong Luo, Su Jingwen, Ruixin Sun, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 20, pp. 5494-5505
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Darel Martínez Bedoya, Valérie Dutoit, Denis Migliorini
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 111
Genetic engineering of T cells for immunotherapy
Gavin I. Ellis, Neil C. Sheppard, James L. Riley
Nature Reviews Genetics (2021) Vol. 22, Iss. 7, pp. 427-447
Open Access | Times Cited: 105
Utilizing chemokines in cancer immunotherapy
Florian Märkl, Duc Huynh, Stefan Endres, et al.
Trends in cancer (2022) Vol. 8, Iss. 8, pp. 670-682
Closed Access | Times Cited: 100
How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 92
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
Yifan Liu, Yansha Sun, Peng Wang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Immunotherapy in glioblastoma treatment: Current state and future prospects
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 4, pp. 138-159
Open Access | Times Cited: 51
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 28
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 17
Engineered Cytokine Signaling to Improve CAR T Cell Effector Function
Matthew Bell, Stephen Gottschalk
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Engineering better chimeric antigen receptor T cells
Hao Zhang, Pu Zhao, He Huang
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 84
Improving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10828-10828
Open Access | Times Cited: 73
Harnessing the chemokine system to home CAR-T cells into solid tumors
Jade Foeng, Iain Comerford, Shaun R. McColl
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100543-100543
Open Access | Times Cited: 67
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
Miriam Kim, Reyka G. Jayasinghe, Jessica M. Devenport, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
IL-7: Comprehensive review
Hila Winer, Gisele Rodrigues, Julie A. Hixon, et al.
Cytokine (2022) Vol. 160, pp. 156049-156049
Closed Access | Times Cited: 62
Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer
Cong Chen, Yanmei Gu, Fan Zhang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 61
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
Alain E. Andrea, Andrada Chiron, Sarah Mallah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Modulating tumor physical microenvironment for fueling CAR-T cell therapy
Zhong Luo, Xuemei Yao, Menghuan Li, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114301-114301
Closed Access | Times Cited: 39
Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer
Mulong Du, Dongying Gu, Junyi Xin, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 3, pp. 100974-100974
Open Access | Times Cited: 32
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
Eric Hee Jun Lee, John P. Murad, Lea Christian, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 32
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer
Ruixin Sun, Yansha Sun, Chuanlong Wu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3193-3209
Open Access | Times Cited: 30
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
Esther Schoutrop, Thomas Poiret, Ibrahim El‐Serafi, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005691-e005691
Open Access | Times Cited: 29
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment
Na Zhang, Xiaohong Liu, Juliang Qin, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2575-2590
Open Access | Times Cited: 26
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
Yidan Qiao, Jie Chen, Xuemei Wang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 788-807
Open Access | Times Cited: 25
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma
Sheridan L. Swan, Nalini Mehta, Ekaterina Ilich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top